Asher Biotherapeutics Stock

asherbio.comHealthcareFounded: 2019Funding to Date: $166.65MM

Asher Bio is a biotech company developing precisely targeted immunotherapies for cancer and other diseases.

Register for Details

For more details on financing and valuation for Asher Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Asher Biotherapeutics.

Register Today

Other companies like Asher Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector